Baxter International Inc. (NYSE:BAX) said that it plans to spin off its kidney care units into an independent, publicly traded company in the next 12-18 months. Baxter is also exploring alternatives for its BioPharma Solutions business, including a potential sale or other separation options, the company said.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.65 USD | +2.00% |
|
+1.65% | -10.58% |
12:17pm | North American Morning Briefing : Retail Sales, -2- | DJ |
15/07 | Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.58% | 17.31B | |
-6.36% | 179B | |
-5.93% | 98.84B | |
-6.40% | 65.34B | |
+15.46% | 45.41B | |
-7.15% | 44.94B | |
+9.72% | 43.76B | |
+13.14% | 29.01B | |
+19.39% | 25.65B | |
-6.70% | 23.32B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Baxter International Plans to Spin Off Kidney Care Units